{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:01:35Z","timestamp":1785074495083,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189596","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:45:32Z","timestamp":1776959132000},"page":"189596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights"],"prefix":"10.1016","volume":"1881","author":[{"given":"Laurie","family":"De Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Gu\u00e9guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189596_bb0005","article-title":"Incidence des principaux cancers en france m\u00e9tropolitaine en 2023 et tendances depuis 1990","author":"Lap\u00f4tre-Ledoux","year":"2023","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire - BEH"},{"key":"10.1016\/j.bbcan.2026.189596_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: A review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2026.189596_bb0020","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbcan.2026.189596_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbcan.2026.189596_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: findings and clinical implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0040","first-page":"8","article-title":"What's new in the WHO 2022 classification of kidney tumours?","volume":"115","author":"Alaghehbandan","year":"2022","journal-title":"Pathologica"},{"key":"10.1016\/j.bbcan.2026.189596_bb0045","author":"COSMIC"},{"key":"10.1016\/j.bbcan.2026.189596_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Creighton","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189596_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189596_bb0060","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The metabolic basis of kidney cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189596_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103287","article-title":"Comprehensive review of chromophobe renal cell carcinoma","volume":"160","author":"Garje","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189596_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/curroncol32060359","article-title":"Molecular genetics of renal cell carcinoma: a narrative review focused on clinical relevance","volume":"32","author":"Millan","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0080","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/oemed-2012-100932","article-title":"Occupational trichloroethylene exposure and kidney cancer risk: a meta-analysis","volume":"69","author":"Karami","year":"2012","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.kint.2021.03.011","article-title":"From kidney injury to kidney cancer","volume":"100","author":"Peired","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbcan.2026.189596_bb0090","series-title":"Species Differences in Thyroid Kidney and Urinary Bladder Carcinogenesis - IARC n\u00b0147","author":"IARC","year":"1999"},{"key":"10.1016\/j.bbcan.2026.189596_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084397","article-title":"Review of knowledge of uranium-induced kidney toxicity for the development of an adverse outcome pathway to renal impairment","volume":"23","author":"Gu\u00e9guen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5271\/sjweh.2249","article-title":"Renal toxicity in uranium mill workers","volume":"11","author":"Thun","year":"1985","journal-title":"Scand. J. Work Environ. Health"},{"key":"10.1016\/j.bbcan.2026.189596_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/toxsci\/43.1.68","article-title":"Chronic ingestion of uranium in drinking water: a study of kidney bioeffects in humans","volume":"43","author":"Zamora","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.ajkd.2006.03.002","article-title":"Kidney toxicity of ingested uranium from drinking water","volume":"47","author":"Kurttio","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbcan.2026.189596_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00411-014-0547-4","article-title":"Kidney cancer mortality and ionizing radiation among french and german uranium miners","volume":"53","author":"Drubay","year":"2014","journal-title":"Radiat. Environ. Biophys."},{"key":"10.1016\/j.bbcan.2026.189596_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00420-014-0998-6","article-title":"Mortality analyses in the updated french cohort of uranium miners (1946-2007)","volume":"88","author":"Rage","year":"2015","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.bbcan.2026.189596_bb0125","first-page":"1","article-title":"Updated mortality analysis of the Mallinckrodt uranium processing workers, 1942-2012","author":"Golden","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ajim.22858","article-title":"Dose-response relationships between internally-deposited uranium and select health outcomes in gaseous diffusion plant workers, 1948-2011","volume":"61","author":"Yiin","year":"2018","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0146645318756247","article-title":"Cancer risk following alpha-emitter exposure","volume":"47","author":"Tirmarche","year":"2018","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.bbcan.2026.189596_bb0140","series-title":"Sources, Effects and Risks of Ionizing Radiation - Annex D Uranium","author":"UNSCEAR","year":"2016"},{"key":"10.1016\/j.bbcan.2026.189596_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100745","article-title":"Choosing the right animal model for renal cancer research","volume":"13","author":"Sobczuk","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0150","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41388-020-1234-3","article-title":"Modeling clear cell renal cell carcinoma and therapeutic implications","volume":"39","author":"Wolf","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189596_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871252","article-title":"Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics","volume":"12","author":"Shapiro","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0160","unstructured":"ATCC, Renca - CRL-2947, Https:\/\/Www.Atcc.Org (2025). https:\/\/www.atcc.org\/products\/crl-2947 (accessed November 7, 2025)."},{"key":"10.1016\/j.bbcan.2026.189596_bb0165","first-page":"3358","article-title":"Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes1","volume":"46","author":"Salup","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4049\/jimmunol.138.2.641","article-title":"Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy","volume":"138","author":"Salup","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0175","first-page":"2399","article-title":"Efficacy of sequential treatment with sunitinib-Everolimus in an orthotopic mouse model of renal cell carcinoma","volume":"32","author":"Larkin","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00280-006-0393-4","article-title":"Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models","volume":"59","author":"Chang","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0185","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/carcin\/bgr021","article-title":"2\u2032-Hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma","volume":"32","author":"Nagaprashantha","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189596_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13550-014-0027-5","article-title":"Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy","volume":"4","author":"Chapman","year":"2014","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/15548627.2024.2421699","article-title":"Atractylenolide i inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1\/HIF2\u03b1","volume":"21","author":"Li","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2026.189596_bb0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/path.2929","article-title":"Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients","volume":"225","author":"Grisanzio","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0205","doi-asserted-by":"crossref","first-page":"59336","DOI":"10.18632\/oncotarget.10659","article-title":"Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma","volume":"7","author":"Lang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189596_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003643","article-title":"A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma","volume":"4","author":"Sivanand","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.euf.2016.08.005","article-title":"Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: feasibility of using biopsy samples","volume":"3","author":"Dong","year":"2017","journal-title":"Eur. Urol. Focus."},{"key":"10.1016\/j.bbcan.2026.189596_bb0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/bjc.1977.251","article-title":"Streptozotocin-induced renal tumours in rats","volume":"36","author":"Horton","year":"1977","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189596_bb0225","first-page":"6255","article-title":"Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype1","volume":"61","author":"Gruys","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0230","first-page":"366","article-title":"Ultrastructural aspects of renal adenocarcinoma induced in the rat by dimethylnitrosamine","volume":"31","author":"Hard","year":"1971","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0235","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/carcin\/5.8.1047","article-title":"High frequency, single-dose model of renal adenoma\/carcinoma induction using dimethylnitrosamine in crl: (W)BR rats","volume":"5","author":"Hard","year":"1984","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189596_bb0240","first-page":"2806","article-title":"Cellular analysis of renal neoplasia: light microscope study of the development of interstitial lesions induced in the rat kidney by a single carcinogenic dose of dimethylnitrosamine","volume":"30","author":"Hard","year":"1970","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0245","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jnci\/54.5.1085","article-title":"In vitro culture of cells isolated from Dimethylnitrosamine-induced renal mesenchymal tumors of the rat. i. Qualitative morphology2","volume":"54","author":"Hard","year":"1975","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2026.189596_bb0250","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1349-7006.1995.tb03308.x","article-title":"Low incidence of point mutations in h-, k- and n-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of wistar rats induced by ferric nitrilotriacetate","volume":"86","author":"Nishiyama","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-012-1373-0","article-title":"Characterization of n-diethylnitrosamine-initiated and ferric nitrilotriacetate-promoted renal cell carcinoma experimental model and effect of a tamarind seed extract against acute nephrotoxicity and carcinogenesis","volume":"369","author":"Vargas-Olvera","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189596_bb0260","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/carcin\/19.6.1133","article-title":"Ferric nitrilotriacetate promotes n-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress","volume":"19","author":"Athar","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189596_bb0265","first-page":"107","article-title":"Nephrotoxicity and renal cell carcinoma after use of iron- and Aluminum-nitrilotriacetate complexes in rats2","volume":"76","author":"Ebina","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2026.189596_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189596_bb0280","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/onc.2014.17","article-title":"Renal tumours in a tsc2(+\/\u2212) mouse model do not show feedback inhibition of akt and are effectively prevented by rapamycin","volume":"34","author":"Yang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189596_bb0285","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"MTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189596_bb0290","doi-asserted-by":"crossref","first-page":"58504","DOI":"10.18632\/oncotarget.17215","article-title":"The dual PI3K\/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in tsc2+\/\u2212 mice through suppression of cell proliferation and induction of apoptosis","volume":"8","author":"Narov","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189596_bb0295","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-16-2458","article-title":"P62\/SQSTM1 cooperates with hyperactive mTORC1 to regulate glutathione production, maintain mitochondrial integrity, and promote tumorigenesis","volume":"77","author":"Lam","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0300","doi-asserted-by":"crossref","first-page":"32900","DOI":"10.18632\/oncotarget.26004","article-title":"A new drug combination significantly reduces kidney tumor progression in kidney mouse model","volume":"9","author":"Liang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189596_bb0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neo.2018.12.003","article-title":"Efficacy of dual inhibition of glycolysis and glutaminolysis for therapy of renal lesions in tsc2+\/\u2212 mice","volume":"21","author":"Jones","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189596_bb0310","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/carcin\/bgy172","article-title":"Heterozygous tsc2 (tsc2+\/\u2212) mouse model to study induced renal cancer in response to ionizing radiation at low doses","volume":"40","author":"Sureshkumar","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189596_bb0315","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/cas.14307","article-title":"Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in eker rats","volume":"111","author":"Inoue","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0320","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4343","article-title":"Combined mutation in vhl, trp53 and rb1 causes clear cell renal cell carcinoma in mice","volume":"23","author":"Harlander","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0325","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.celrep.2017.02.074","article-title":"The SWI\/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma","volume":"18","author":"Nargund","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189596_bb0330","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.4736","article-title":"Combined deletion of vhl, trp53 and kif3a causes cystic and neoplastic renal lesions","volume":"239","author":"Guinot","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0335","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/0008-5472.CAN-15-1859","article-title":"Formation of renal cysts and tumors in Vhl\/Trp53-deficient mice requires HIF1\u03b1 and HIF2\u03b1","volume":"76","author":"Sch\u00f6nenberger","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0340","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.celrep.2018.06.106","article-title":"MTORC1 upregulation leads to accumulation of the oncometabolite fumarate in a mouse model of renal cell carcinoma","volume":"24","author":"Drusian","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189596_bb0345","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1158\/0008-5472.CAN-20-3960","article-title":"Multilevel regulation of \u03b2-catenin activity by SETD2 suppresses the transition from polycystic kidney disease to clear cell renal cell carcinoma","volume":"81","author":"Rao","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0350","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling renal cell carcinoma in mice: Bap1 and pbrm1 inactivation drive tumor grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189596_bb0355","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/sj.bjc.6602597","article-title":"Expression of ksp-cadherin during kidney development and in renal cell carcinoma","volume":"92","author":"Thedieck","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189596_bb0360","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.3390\/ijms25126730","article-title":"The role of the PAX genes in renal cell carcinoma","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408549121","article-title":"Toward a CRISPR-based mouse model of vhl-deficient clear cell kidney cancer: initial experience and lessons learned","volume":"121","author":"Stransky","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0370","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1414789111","article-title":"Bap1 is essential for kidney function and cooperates with vhl in renal tumorigenesis","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189596_bb0375","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/0008-5472.CAN-20-2930","article-title":"Acute kidney injury instigates malignant renal cell carcinoma via CXCR2 in mice with inactivated trp53 and pten in proximal tubular kidney epithelial cells","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0380","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0385","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189596_bb0390","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/emmm.201202231","article-title":"Combined mutation of vhl and trp53 causes renal cysts and tumours in mice","volume":"5","author":"Albers","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0395","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.24841","article-title":"P53 and MDM2 in renal cell carcinoma","volume":"116","author":"Noon","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189596_bb0400","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10147-019-01564-1","article-title":"Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor","volume":"25","author":"Cai","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0405","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.kint.2024.12.003","article-title":"Mutations in tumor suppressor genes vhl and rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma","volume":"107","author":"Catalano","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbcan.2026.189596_bb0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gendis.2021.03.010","article-title":"Tsc2 mutation induces renal tubular cell nonautonomous disease","volume":"9","author":"Kumar","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbcan.2026.189596_bb0415","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-hogg-Dub\u00e9 gene inactivation in a mouse model","volume":"100","author":"Baba","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2026.189596_bb0420","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/onc.2009.14","article-title":"The role of the Birt-hogg-Dub\u00e9 protein in mTOR activation and renal tumorigenesis","volume":"28","author":"Hartman","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189596_bb0425","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189596_bb0430","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.2009.072009","article-title":"Renal tumour suppressor function of the Birt\u2013hogg\u2013Dub\u00e9 syndrome gene product folliculin","volume":"47","author":"Hudon","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbcan.2026.189596_bb0435","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2015.177","article-title":"Disruption of tubular flcn expression as a mouse model for renal tumor induction","volume":"88","author":"Chen","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbcan.2026.189596_bb0440","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ajpath.2025.05.010","article-title":"Folliculin deletion in the mouse kidney results in cystogenesis of the loops of Henle via aberrant TFEB activation","volume":"195","author":"Shalaby","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0445","doi-asserted-by":"crossref","first-page":"E1624","DOI":"10.1073\/pnas.1419502112","article-title":"Folliculin-interacting proteins fnip1 and fnip2 play critical roles in kidney tumor suppression in cooperation with flcn","volume":"112","author":"Hasumi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189596_bb0450","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17047","article-title":"Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling","volume":"5","author":"Calcagn\u00ec","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.bbcan.2026.189596_bb0455","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1541-7786.MCR-18-1235","article-title":"TFE3 Xp11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease","volume":"17","author":"Baba","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189596_bb0460","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.3390\/ijms23147649","article-title":"MiTF\/TFE translocation renal cell carcinomas: from clinical entities to molecular insights","volume":"23","author":"Simonaggio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189596_bb0465","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1038\/s41467-025-63885-2","article-title":"SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesis","volume":"16","author":"Asrani","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189596_bb0470","doi-asserted-by":"crossref","first-page":"60971","DOI":"10.18632\/oncotarget.11275","article-title":"Vhl deletion in renal epithelia causes HIF-1\u03b1-dependent, HIF-2\u03b1-independent angiogenesis and constitutive diuresis","volume":"7","author":"Sch\u00f6nenberger","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189596_bb0475","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2026.189596_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112953","article-title":"Diagnostic and prognostic biomarkers in renal clear cell carcinoma","volume":"10","author":"Weaver","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189596_bb0485","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189596_bb0490","article-title":"The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and ki-67 tissue markers in localized renal cell carcinoma: a retrospective study of tissue microarrays using immunohistochemistry","volume":"12","author":"Kim","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bbcan.2026.189596_bb0495","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/onc.2014.197","article-title":"Conditional inactivation of the mouse von Hippel-Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney","volume":"34","author":"Pritchett","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189596_bb0500","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.fct.2013.10.004","article-title":"Consumption of hydrogen-rich water protects against ferric nitrilotriacetate-induced nephrotoxicity and early tumor promotional events in rats","volume":"61","author":"Li","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0505","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2015.01.006","article-title":"Lycopene in the prevention of renal cell cancer in the TSC2 mutant eker rat model","volume":"572","author":"Sahin","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2026.189596_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2016.07.004","article-title":"Inhibition of precancerous lesions development in kidneys by chrysin via regulating hyperproliferation, inflammation and apoptosis at pre clinical stage","volume":"606","author":"Rashid","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2026.189596_bb0515","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10787-017-0310-y","article-title":"Novel glycoside from wedelia calendulacea inhibits diethyl nitrosamine-induced renal cancer via downregulating the COX-2 and PEG2 through nuclear factor-\u03baB pathway","volume":"25","author":"Verma","year":"2017","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.bbcan.2026.189596_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6003","article-title":"Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells","volume":"12","author":"Peired","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0525","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5858\/arpa.2011-0472-RA","article-title":"Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?","volume":"136","author":"Shen","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0530","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PAS.0b013e318299f12e","article-title":"ISUP renal tumor panel, renal tumors: diagnostic and prognostic biomarkers","volume":"37","author":"Tan","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0535","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/pin.12080","article-title":"Recent advances of immunohistochemistry for diagnosis of renal tumors","volume":"63","author":"Kuroda","year":"2013","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbcan.2026.189596_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.semdp.2021.11.001","article-title":"Immunohistochemistry for the diagnosis of renal epithelial neoplasms","volume":"39","author":"Akgul","year":"2022","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0545","doi-asserted-by":"crossref","first-page":"79","DOI":"10.20892\/j.issn.2095-3941.2018.0170","article-title":"P53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis","volume":"16","author":"Li","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189596_bb0550","first-page":"903","article-title":"Deducing the stage of origin of wilms tumours from a developmental series of wt1-mutant mice","volume":"8","author":"Berry","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbcan.2026.189596_bb0555","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1534\/g3.119.400161","article-title":"Long-term combinatorial exposure to trichloroethylene and inorganic arsenic in genetically heterogeneous mice results in renal tubular damage and cancer-associated molecular changes","volume":"9","author":"Perry","year":"2019","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.bbcan.2026.189596_bb0560","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/0192623312438736","article-title":"Proliferative and nonproliferative lesions of the rat and mouse urinary system","volume":"40","author":"Frazier","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0565","doi-asserted-by":"crossref","first-page":"14249","DOI":"10.1038\/s41598-017-14759-1","article-title":"Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI","volume":"7","author":"Linxweiler","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189596_bb0570","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7150\/thno.19658","article-title":"Ultrasound molecular imaging of VEGFR-2 in clear-cell renal cell carcinoma tracks disease response to antiangiogenic and notch-inhibition therapy","volume":"8","author":"Rojas","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189596_bb0575","first-page":"873","article-title":"Ultrasound measurement of vascular density to evaluate response to anti-angiogenic therapy in renal cell carcinoma","volume":"66","author":"Rojas","year":"2019","journal-title":"I.E.E.E. Trans. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189596_bb0580","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1038\/s41598-020-64433-2","article-title":"Ultrasound molecular imaging of renal cell carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles","volume":"10","author":"Ingels","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189596_bb0585","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41581-021-00440-4","article-title":"Non-invasive molecular imaging of kidney diseases","volume":"17","author":"Klinkhammer","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0590","first-page":"521","article-title":"Pracheta, anti-carcinogenic potential of euphorbia neriifolia leaves and isolated flavonoid against N-Nitrosodiethylamine-induced renal carcinogenesis in mice","volume":"50","author":"Sharma","year":"2013","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2026.189596_bb0595","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.yexmp.2015.11.012","article-title":"Chemopreventive efficacy of hesperidin against chemically induced nephrotoxicity and renal carcinogenesis via amelioration of oxidative stress and modulation of multiple molecular pathways","volume":"99","author":"Siddiqi","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0600","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12935-021-01879-y","article-title":"Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma","volume":"21","author":"Ma","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189596_bb0605","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317699116","article-title":"Interaction of renin\u2013angiotensin system and adenosine monophosphate\u2013activated protein kinase signaling pathway in renal carcinogenesis of uninephrectomized rats","volume":"39","author":"Yang","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0610","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s11255-025-04447-9","article-title":"Liquid-based kidney injury molecule-1 as a diagnostic and prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis","volume":"57","author":"He","year":"2025","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.bbcan.2026.189596_bb0615","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17691\/stm2021.13.3.08","article-title":"Kidney injury molecule 1 (KIM-1): a multifunctional glycoprotein and biological marker (review)","volume":"13","author":"Karmakova","year":"2021","journal-title":"Sovrem Tekhnologii Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:26:04Z","timestamp":1785072364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26000685"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189596","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189596"}}